Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
US dollar bonds fluctuate | Jiayu Group KAISAG 7 12/28/31 price dropped by 1.658% to 2.123.
11/11/2025
On November 11th, the KAISAG 7 12/28/31 issued by Evergrande Group is now priced at 2.123, with a decrease of -1.658% in yield.
Latest
7 m ago
Xtant Medical Holdings (XTNT.US): The Q3 financial report for 2025 achieved revenue of $33.3 million, up from $27.937 million, and exceeding the expected value of $32.695 million; earnings per share were $0.01, an improvement from -$0.04, but slightly below the expected value of -$0.02.
8 m ago
VirTra (VTSI.US): The financial report of the third quarter of 2025 showed a revenue of 5.35 million US dollars, compared to the previous value of 7.484 million US dollars and an expected value of 7.1872 million US dollars; The earnings per share was -0.03 US dollars, compared to the previous value of 0.05 US dollars and an expected value of 0.04 US dollars.
9 m ago
Passage Bio (PASG.US) reported revenue of 0 US dollars in Q3 2025, compared to 0 US dollars in the previous period; earnings per share were -2.44 US dollars, compared to -6.15 US dollars in the previous period, with an expected value of -2.84 US dollars.
10 m ago
Kaltura (KLTR.US): The Q3 financial report of 2025 achieved a revenue of $43.866 million, compared to the previous value of $44.295 million, and the expected value of $43.24767 million; earnings per share were $0.01, the same as the previous value, with an expected value of -0.01.
11 m ago
ProKidney(PROK.US)The financial report for Q3 2025 shows a revenue of $217,000, compared to $0 in the previous period and an expected value of $44,250. Earnings per share were -$0.12, compared to -$0.14 in the previous period and an expected value of -$0.13.
See all latest